Fast evaluation and monitoring of ingenol mebutate treatment of multiple basal cell carcinomas by in vivo hand‐held reflectance confocal microscopy
- 28 November 2016
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 31 (6) , e284-e286
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- In vivo confocal microscopy of basal cell carcinoma: a systematic review of diagnostic accuracyJournal of the European Academy of Dermatology and Venereology, 2015
- Sensitivity of handheld reflectance confocal microscopy for the diagnosis of basal cell carcinoma: A series of 344 histologically proven lesionsJournal of the American Academy of Dermatology, 2015
- Accuracy of in vivo confocal microscopy for diagnosis of basal cell carcinoma: a comparative study between handheld and wide‐probe confocal imagingJournal of the European Academy of Dermatology and Venereology, 2014
- In Vivo Confocal Microscopy for Diagnosis of Melanoma and Basal Cell Carcinoma Using a Two-Step Method: Analysis of 710 Consecutive Clinically Equivocal CasesJournal of Investigative Dermatology, 2012
- PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: Results of a randomized phase IIa trialAustralasian Journal of Dermatology, 2010
- Sensitivity and specificity of reflectance-mode confocal microscopy for in vivo diagnosis of basal cell carcinoma: A multicenter studyJournal of the American Academy of Dermatology, 2004
- Risk of another basal cell carcinoma developing after treatment of a basal cell carcinomaJournal of the American Academy of Dermatology, 1993